Company Filing History:
2 out of 14 
2 out of 989 
Years Active: 2011-2012
Title: Daichika Hayata: Innovator in HGF Precursor Protein Variants
Introduction
Daichika Hayata is a notable inventor based in Toyonaka, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of HGF precursor protein variants. With a total of 2 patents, his work has the potential to impact various medical applications.
Latest Patents
Hayata's latest patents focus on an HGF precursor protein variant. This variant includes a peptide structure that comprises a sequence with a peptide chain X inserted between the α chain of HGF and the β chain of HGF. The design allows for specific modifications, such as deleting amino-acid residues from the C-terminus of the α chain and the N-terminus of the β chain. The peptide chain X has an amino-acid sequence of at least two residues and can be cleaved by a protease or chemical reaction, resulting in a protein that exhibits HGF action.
Career Highlights
Throughout his career, Daichika Hayata has worked with reputable organizations, including Kringle Pharma Inc. and Osaka University. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Toshikazu Nakamura and Kunio Matsumoto. Their collaborative efforts have further advanced the research and development of innovative protein variants.
Conclusion
Daichika Hayata's work in the field of HGF precursor protein variants showcases his dedication to innovation and research. His contributions are paving the way for future advancements in biotechnology and medicine.